Abstract
Renal cell carcinoma (RCC) is the most common malignant tumor of the kidney, accounting for about 80–90% of kidney tumors in adults and about 2–3% of all new cancer cases (Mori et al. 1998). RCC occurs twice as likely in men as in women, with the highest incidence in the age of 50–70 years (Muscat 2000). Each year, 30,000 and 20,000 new cases of kidney cancer are reported in the USA and in the European Union, respectively (Kirkali et al. 2001). In Russia, RCC occupies one of the first places among all forms of cancer in terms of the incidence rate: the number of cases in recent years approaches 20 thousand per year. Mortality rates from this disease in Russia are also high, 8000–9000 per year, accounting for 2–3% of all deaths of patients with malignant tumors. The 5-year survival in patients is 80–90% and 5–10% with localized and disseminated RCC forms, respectively (Motzer et al. 2004).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsBibliography
Badalament R, Kreutzer E, Gluck R, et al. Surgical treatment of brain metastases from renal cell carcinoma. Urology. 1990;36:112–7.
Baltaci S, Orhan D, Soyupek S, et al. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urol. 2000;164(1):36–9.
Bianchi M, Sun M, Jeldres C, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23(4):973–80.
Blanco A, Teh S, Amato R. Role of radiation therapy in the management of renal cell cancer. Cancers. 2011;3:4010–23.
Clague J, Lin J, Cassidy A, et al. Family history and risk of renal cell carcinoma: results from a case–control study and systematic meta-analysis. Cancer Epidemiol Biomark Prev. 2009;18:801–7.
Coppic C, Porzsot F, Awa A, et al. Immunotherapy for advanced renal cancer. Cochrane Database Syst Rev. 2000;1:CD001425.
Coughlin S, Neaton J, Randall B, et al. Predictors of mortality from kidney cancer in 332 547 men screened for the Multiple Risk Factor Intervention Trial. Cancer. 1997;79:2171–7.
Crispen P, Lohse C, Blute M. Multifocal renal cell carcinoma: clinicopathologic features and outcomes for tumors ≤4 cm. Adv Urol. 2008;2008:7.
Davydov MI, Axel EM. Statistics of malignancies in Russia and the CIS in 2012. Moscow: IOP Science; 2014a. p. 39–42.
Davydov MI, Axel EM. Statistics of malignancies in Russia and the CIS in 2012. Moscow: M. Publishing Group of Russian Cancer Research Center; 2014b. p. 226.
Godley P, Stinchcombe T. Renal cell carcinoma. Curr Opin Oncol. 1999;11(3):213–7.
Gohji K, Hara I, Gotoh A, et al. Multifocal renal cell carcinoma in Japanese patients with tumors with maximal diameters of 50 mm or less. J Urol. 1998;159(4):1144–7.
Harada Y, Nonomura N, Kondo M, et al. Clinical study of brain metastasis of renal cell carcinoma. Eur Urol. 1999;36:230–5.
Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2007;57(1):43–66.
Karami S, Schwartz K, Purdue M, et al. Family history of cancer and renal cell cancer risk in Caucasians and African Americans. Br J Cancer. 2010;102(11):1676–80.
Kirkali Z, Tuz E, Mungan M. Recent advances in kidney cancer and metastatic disease. BJU Int. 2001;88:818–24.
Kleinberg L. Brain metastases: a multidisciplinary approach. New York: Demos; 2009. p. 224.
Kusuda Y, Miyake H, Terakawa T, et al. Treatment of brain metastases from renal cell carcinoma with sunitinib and radiotherapy: our experience and review of the literature. Int J Urol. 2011;18:326–9.
Lang H, Lindner V, Martin M, et al. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur Urol. 2004;45(6):749–53.
Lindblad P, Mellemgaard A, Schlehofer B, et al. International renal-cell cancer study. V. Reproductive factors, gynecologic operations and exogenous hormones. Int J Cancer. 1995;61:192–8.
Liu H, Wang X, Zhou G, et al. Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein. Gynecol Oncol. 2011;122:430–6.
Ljungberg B, Campbell S, Choi H, et al. The epidemiology of renal cell carcinoma. Eur Urol. 2011;60:615–21.
Loudyi A, Samlowski W. Brain metastasis in renal cell carcinoma patients. Chapter 6. In: Hayat MA, editor. Tumors of the central nervous system, vol. 3. Dordrecht: Springer; 2011.
Marshall M, Butler K, Pearson T, et al. Low incidence of asymptomatic brain metastases in patients with renal cell carcinoma. Urology. 1990;36:300–2.
Mori Y, Kondziolka D, Flickinger J, et al. Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival. Int J Radiat Oncol Biol Phys. 1998;42:581–9.
Motzer R, Bacik J, Schwartz L, et al. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol. 2004;22(3):454–63.
Muscat J. The epidemiology of renal cell carcinoma. In: Bukowski RM, Novick AC, editors. Renal cell carcinoma: molecular biology, immunology, and clinical Management. Totowa: Human Press; 2000. p. 3–13.
Nieder C, Spanne O, Mehta M, et al. Presentation, patterns of care, and survival in patients with brain metastases: what has changed in the last 20 years? Cancer. 2011a;117(11):2505–12.
Nieder C, Spanne O, Nordoy T, et al. Treatment of brain metastases from renal cell cancer. Urol Oncol. 2011b;29(4):405–10.
Nussbaum E, Djalilian H, Cho K, et al. Brain metastases. Histology, multiplicity, surgery, and survival. Cancer. 1996;78(8):1781–8.
Parashar B, Patro K, Smith M, et al. Role of radiation therapy for renal tumors. Semin Intervent Radiol. 2014;31(1):86–90.
Patchell R, Tibbs P, Walsh J, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990a;322:753–9.
Patchell R, Tibbs P, Walsh J, et al. A randomized trial of surgery in the treatment of single metastases to the brain. New Engl J Med. 1990b;322(8):494–500.
Pfaffenroth E, Linchan W. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther. 2008;8(6):779–90.
Radley M, McDonald J, et al. Late solitary cerebral metastases from renal cell carcinoma: report of two cases. Surg J Neurol. 1993;39:230–4.
Raman R, Vaena D. Immunotherapy in metastatic renal cell carcinoma: a comprehensive review. Biomed Res Int. 2015;2015:8.
Richstone L, Scherr D, Reuter V, et al. Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival. J Urol. 2004;171(2, part 1):615–20.
Roser F, Rosahl S, Samii M. Single cerebral metastasis 3 and 19 years after primary renal cell carcinoma: case report and review of the literature. J Neurol Neurosurg Psychiatry. 2002;72(2):257–8.
Saitoh H. Distant metastasis of renal adenocarcinoma. Cancer. 1981;48:1487–91.
Shus AV. Optimization of diagnostic and treatment tactics in multifocal renal cancer. Intern Med J. 2003;9(3):95–7.
Steliarova-Foucher E, Parkin D. Cancer registration in Europe. In: Razum O, Spallek J, Reeske A, Arnold M, editors. Migration-sensitive cancer registration in Europe. Challenges and potentials. Frankfurt: Peter Lang Verlag; 2011.
Wronski M, Arbit E, Bilsky M, et al. Resection of brain metastases (BMET) from breast cancer (BRC): retrospective review of 70 patients (Meeting abstract). Proc An Meet ASCO 1996;15:A165.
Yurin AG. Epidemiology, new in classification of kidney cancer. Arch Pathol. 2007;69(1):49–54.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Dolgushin, M., Kornienko, V., Pronin, I. (2018). Renal Cell Carcinoma (RCC). In: Brain Metastases. Springer, Cham. https://doi.org/10.1007/978-3-319-57760-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-57760-9_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57758-6
Online ISBN: 978-3-319-57760-9
eBook Packages: MedicineMedicine (R0)